NCT01229423View on ClinicalTrials.gov

Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects

PHASE4CompletedINTERVENTIONAL

Enrollment

62

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

October 31, 2010

Conditions

Eyelash Hypotrichosis

Interventions

DRUG

bimatoprost 0.03%

One drop of bimatoprost 0.03% (LATISSE®) applied evenly to each upper eyelid in the evening. Treatment is once daily for up to 40 weeks.

Trial Locations (1)

Unknown

Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Allergan

INDUSTRY